This is the authors' abstract. We don't add key points for this paper.
A clinical study and the analysis of transthyretin (TTR) abnormality were performed on a family with familial amyloid polyneuropathy (FAP) that had recently been found in China. Fourteen members over four generations were affected and their clinical pictures were consistent with those of type I FAP Using a matrix-assisted laser desorption ion-izatiod time- oS-flight mass spectrometry system, a TTR variant which possibly corresponded to Met 30 TTR was easily identified in the sera of patients and then, Met 30 TTR gene abnormality was confirmed on PCR-RFLP analysis. It is suggested that mass spectrometry system is a useful procedure for screening variant TTRs in the sera of large populations.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ikeda et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: